Target intelligence / Profile preview

NME2 pseudogene 3 (NME2P3)

Target: NME2P3
Molecular classification: Other (Pseudogene)

Overview

NME2 pseudogene 3 (NME2P3) is a processed pseudogene resembling NME2, which encodes nucleoside diphosphate kinase B, but NME2P3 itself does not encode a functional protein and is generally not transcribed or translated. Pseudogenes like NME2P3 may have subtle regulatory roles or serve as a source for non-coding RNAs, but there is no evidence that NME2P3 acts as a receptor, enzyme, transporter, or other direct therapeutic target[4][5]. The gene does not have well-established biological functions and has no known drug interactions, biomarker utility, or associated safety concerns.

Other names: NME2P3NME2 pseudogene 3

Beyond the preview

Go deeper on NME2 pseudogene 3 (NME2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NME2 pseudogene 3 (NME2P3).

Explore the full profile